$XBI $113.21 -1.7%%
Covid Updates
$DVAX -1.3% COVID-19 Vaccine Developed by Biological E Using Dynavax's CpG 1018 Adjuvant Receives India DCGI Approval for Emergency Use source
$NVAX -1.2% Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India source
$KNSA -2.9% Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS source
Pipeline Updates
$
Business Updates
$DRNA -0.8% Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition source
Posted by JM
Comments